Julie Sutcliffe was awarded an RC4 in the total amount of $3.5 million . This was a proposal in response to the “NIH Directors opportunity for Five Thematic Areas”. The grant is titled “High throughput design, synthesis and /in vivo/ evaluation of targeted molecular imaging agents”. This is a team effort between Sutcliffe, Cherry, Revzin and Qi.